SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Jasper Therapeutics, Inc.
@JSPR_InsiderForm 4 Filing: Crutcher Patrick J Acquires (Grant) shares of $JSPR
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Jasper Therapeutics, Inc.
Ticker: $JSPR
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-16
Shares: 15,888
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Crutcher Patrick J, holds the title of Director at Jasper Therapeutics, Inc..
On 2026-07-16, the insider transacted 15,888 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Crutcher Patrick J (Director) was granted $0 of $JSPR
Post-Transaction Position: 15,000 shares
SEC Accession No: 0001213900-26-079764 (CIK: 1754540)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.